This Biotech Leader Ran Up As Much As 18% — And Then Lost It All
Shares of Design Therapeutics experienced a significant surge on Monday following positive results in the treatment of Friedreich's ataxia, reaching an increase of up to 18%. However, the biotech company quickly saw these gains disappear. This fluctuation underscores the volatile nature of the market, illustrating the rapid shifts that can occur in stock value. Investors Business Daily covered this story, highlighting the rollercoaster ride that Design Therapeutics' shares took on this particular day.
Source: Unusual Whales The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments